Biograil ApS
CVR 40666699 · Private limited company (ApS) · Active · Low risk
Biograil ApS is a Private limited company (ApS), founded on , based in Roskilde. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.1 times the average for Danish companies. 6 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 102.2m and a net result of DKK -22.4m. CEO: Karsten Lindhardt.
Bankruptcy risk for Biograil ApS
0.1 × the average (1.41%) · higher risk than 38% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 40666699
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (7 years)
- Address
- Langebjerg 1
4000 Roskilde - Municipality
- Roskilde
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 581k
- Auditor
- Beierholm Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 6 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 93.9% |
| Current ratio | 1,598% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 50 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -13.2m | DKK 4.8m | DKK -15.2m |
| Net profit | DKK -22.4m | DKK -17.1m | DKK -34.8m |
| Equity | DKK 102.2m | DKK 18.8m | DKK 10.0m |
| Total assets | DKK 108.8m | DKK 75.1m | DKK 76.2m |
| Cash | DKK 88.4m | DKK 63.1m | – |
| Short-term debt | DKK 6.6m | DKK 56.3m | – |
| Avg. employees | 20 | 18 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Beierholm.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 110 | ||
| 1 Jan 2024 – 31 Dec 2024 | 162 | ||
| 1 Jan 2023 – 31 Dec 2023 | 170 | ||
| 1 Jan 2022 – 31 Dec 2022 | 185 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 182 | ||
| 17 Jul 2019 – 31 Dec 2020 | 153 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Karsten Lindhardt | Current | |
| Board | Lars Hellerung Christiansen | Current | |
| Board | John Michael Barberich | Current | |
| Board | Karsten Lindhardt | Current | |
| Board | Steffen Wagner | Current | |
| Board | Ulrik Schulze | Current | |
| Board | Robert Samuel | Current | |
| Board | Karsten Lindhardt | ||
| Board | Anke Cassing | ||
| Owner (5%) | High-Tech Gründer-fonds III GmbH & Co. KG | Current | |
| Owner (5%) | Lindhardt Holdings ApS | Current | |
| Owner (15%) | MTI Biograil Invest A/S | Current | |
| Owner (10%) | Eli Lilly and Company | Current | |
| Owner (15%) | Verve Capital Partners AG | Current | |
| Owner (5%) | HTGF Opportunity GmbH & Co. KG | Current | |
| Owner (15%) | HELLERUNG ApS | ||
| Owner (25%) | Lindhardt Holdings ApS | ||
| Owner (10%) | John Michael Barberich | ||
| Owner (5%) | Skak Tosanian Holding ApS | ||
| Owner (5%) | Megatrend Invest A/S | ||
| Owner (5%) | High-Tech Gründer-fonds III GmbH & Co. KG | ||
| Owner (10%) | Egalet Limited | ||
| Owner (10%) | HELLERUNG ApS | ||
| Owner (20%) | Lindhardt Holdings ApS | ||
| Owner (10%) | Megatrend Invest A/S | ||
| Owner (10%) | High-Tech Gründer-fonds III GmbH & Co. KG | ||
| Owner (10%) | Lindhardt Holdings ApS | ||
| Owner (20%) | Megatrend Invest A/S | ||
| Owner (5%) | John Michael Barberich | ||
| Owner (10%) | High-Tech Gründer-fonds III GmbH & Co. KG | ||
| Owner (5%) | Egalet Limited | ||
| Owner (10%) | High-Tech Gründer-fonds III GmbH & Co. KG | ||
| Owner (10%) | Verve Investment Syndicates GmbH | ||
| Owner (5%) | Alligator IP, LLP | ||
| Owner (10%) | Lindhardt Holdings ApS | ||
| Owner (5%) | SR J Sanner GmbH | ||
| Owner (20%) | MTI Biograil Invest A/S | ||
| Owner (15%) | MTI Biograil Invest A/S | ||
| Owner (15%) | Verve Investment Syndicates GmbH | ||
| Owner (5%) | HELLERUNG ApS | ||
| Owner (20%) | MTI Biograil Invest A/S | ||
| Owner (10%) | Verve Investment Syndicates GmbH | ||
| Owner (5%) | Roquette Ventures SASU | ||
| Owner (20%) | Verve Investment Syndicates GmbH | ||
| Owner (5%) | Fund Investments S.A. SICAV-RAIF - Verve Venture Fund I | ||
| Owner (15%) | Verve Investment Syndicates GmbH | ||
| Auditor | Beierholm Godkendt Revisionspartnerselskab | Current | |
| Founder | HELLERUNG ApS | Current | |
| Founder | Lindhardt Holdings ApS | Current | |
| Founder | John Michael Barberich | Current |
The CEOs' other companies
Karsten Lindhardt – 6 other companies
- Dlivery Pharma ApS Active
- EGALET A/S Opløst
- Porthos Group ApS Active
- Scantox A/S Active
- Scantox Denmark ApS Active
- Scantox Holding ApS Active
Address history (1 moves)
| Langebjerg 1, 4000 Roskilde | |
| c/o Karsten Lindhardt, Slettehavevej 77, 4690 Haslev |
Other companies at the same address
- VetNet DK A/S Bankrupt
- ACTIO ApS Active
- Affectum ApS Active
- ApS KBIL 38 NR. 2505 Fusioneret
- BENZON PHARMA A/S Fusioneret
- CUPAH ApS Active
- CVforum ApS Active
- CVforum Holding ApS Active
- Cervello A/S Active
- Cervello Øst ApS Active
- DANCABLES ApS Active
- ECONOMIC HOLDING ApS Active
- ECONOMIC SYSTEMS ApS Active
- ERGOTEL HOLDING ApS Active
- IsiCom Denmark A/S Active
- MJ SERVICE A/S Active
- MJ SERVICE HOLDING ApS Active
- MJ Service Holding 2 ApS Active
- NANOCORE ApS Active
- NC AF 21/12 1990 A/S Opløst
- NETTOPHARMA ApS Opløst
- NYCO HOLDINGS 3 ApS Fusioneret
- NYCOMED A/S Fusioneret
- NYCOMED HOLDING ApS Fusioneret
- NYCOMED PHARMA A/S Fusioneret
Similar companies in Roskilde
- Aerbio A/S Roskilde
- Unibio KSA ApS Roskilde
- Unibio USA ApS Roskilde
- Tubular Technologies ApS Roskilde
- Unibio CIS ApS Roskilde
- SMB INNOVATION ApS Roskilde
- Medbroker ApS Gadstrup
- PROXEON BIOSYSTEMS ApS Roskilde
- UNIBIO A/S Roskilde
- Compass Beauty Denmark ApS Roskilde
- BUILD THERAPEUTICS ApS Roskilde
- FISHER BIOIMAGE ApS Roskilde
Questions and answers about Biograil ApS
Has Biograil ApS gone bankrupt?
No, Biograil ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Biograil ApS?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.
Who is the CEO of Biograil ApS?
Karsten Lindhardt is the CEO of Biograil ApS.
Who is the auditor of Biograil ApS?
Biograil ApS most recently used Beierholm Godkendt Revisionspartnerselskab.
When was Biograil ApS founded?
Biograil ApS was founded on 17 July 2019.
What is the equity of Biograil ApS?
Equity was DKK 102.2m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.